Q32 Bio concludes merger deal with Homology Medicines
Clinical stage biotechnology company Q32 Bio has announced the conclusion of its merger with Homology Medicines, for an undisclosed sum.
Page 2 - Agent Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Agent Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Agent Capital Today - Breaking & Trending Today
Deals in brief: Atome raises USD 31 million from parent firm, Asia Partners closes second fund, multiple China and India deals, and more
Bringing you the latest news briefs on fundraising activities in the Asia Pacific.
Source: kr-asia.com
Deals in brief: Semaai, Komunal, and OnCusp secure funding, Etherscan acquires Solscan, multiple China and India deals, and more
Bringing you the latest news briefs on fundraising activities in the Asia Pacific.
Source: kr-asia.com
Cantai Therapeutics Raises Seed Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Q32 Bio and Homology Medicines Announce Merger Agreement
--The combined company will operate as Q32 Bio Inc., advancing the development of Q32 Bio's two clinical development candidates, bempikibart in Phase 2 for the treatment of atopic dermatitis and...
Source: marketscreener.com